CGEM Q2 2022 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CGEMCullinan Therapeutics, Inc.

$894M

Q2 2022 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

$240M

Net Income

$175M

EPS (Diluted)

$3.77

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$667M

Total Liabilities

$63M

Stockholders' Equity

$605M

Cash & Equivalents

$354M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	$240M	-$17M	+1543.5%
Net Income	$175M	-$16M	+1218.6%